Nifekalant
- Generic Name
- Nifekalant
- Drug Type
- Small Molecule
- Chemical Formula
- C19H27N5O5
- CAS Number
- 130636-43-0
- Unique Ingredient Identifier
- 5VZ7GZM43E
Overview
Nifekalant is under investigation in clinical trial NCT03855826 (Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection).
Background
Nifekalant is under investigation in clinical trial NCT03855826 (Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection).
Indication
用于其它抗心率失常药无效或不耐受的严重的室性心率失常、室颤患者的治疗。
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath